Related Experiment Video
Updated: Jul 2, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
What can be expected from nuclear medicine tomorrow?
Jacques Barbet1, Françoise Kraeber-Bodéré, Jean-François Chatal
1Centre de Recherche en Cancérologie Nantes-Angers, INSERM, Université de Nantes, Nantes, France.
Advanced imaging and targeted radionuclide therapy are revolutionizing cancer treatment. These approaches enable personalized medicine by predicting treatment response and improving survival rates for various cancers.
Area of Science:
- Oncology
- Medical Imaging
- Radiochemistry
Background:
- Integrating
- "omics" data with advanced imaging techniques allows for a shift from single biomarkers to comprehensive multi-scale biomarker profiles.
- Multimodality hybrid imaging, such as positron emission tomography-magnetic resonance imaging (PET-MRI), enables visualization of structural, functional, metabolic, cellular, and molecular changes.
Purpose of the Study:
- To explore the role of advanced imaging and targeted radionuclide therapy in developing personalized medicine for cancer treatment.
- To predict patient responses to cancer therapies, including radiotherapy, proton/hadrontherapy, and targeted radionuclide therapy.
- To stratify patients for specific treatment modalities based on individual
- "omic" characterization.
Main Methods:
- Utilizing multimodality hybrid imaging techniques for comprehensive patient and tumor characterization.
- Applying targeted radionuclide therapy, including radiolabeled antibodies and peptides, for disseminated and metastatic diseases.
- Investigating novel approaches such as small molecules, pretargeting, and alpha-emitting radionuclides.
Main Results:
- Targeted radionuclide therapy has demonstrated clinical efficacy in lymphoma and neuroendocrine tumors, with emerging results in solid tumors.
- While tumor shrinkage may be limited, targeted radionuclide therapy has shown to improve progression-free survival and overall survival in specific cases.
- Advanced imaging facilitates accurate prediction of treatment response and patient stratification.
Conclusions:
- The integration of advanced imaging and targeted radionuclide therapy is crucial for the advancement of personalized cancer medicine.
- These modalities offer promising strategies for improving treatment efficacy and patient outcomes in various cancer types.
- Further research into novel radionuclide delivery systems and combination therapies holds significant potential for future cancer treatment.
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Nuclear Transmutation
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
